FibroBiologics

2 clinical trials · Sponsor

Record	Firm	Date
Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care (NCT07096934)	FibroBiologics	2025-09-01
Feasibility Study of Tolerogenic Fibroblasts in Patients With Refractory Multiple Sclerosis (NCT05080270)	FibroBiologics	2020-09-21

Every clearance here is in the API, with alerts when new ones post.